These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36590607)

  • 1. IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals.
    Ouyang L; Li D; Li Z; Ma X; Yuan L; Fan L; Yang Z; Zhang Z; Li C; He Y; Chen X
    Front Psychiatry; 2022; 13():1072380. PubMed ID: 36590607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Inflammatory Markers in Clinical High Risk of Developing Psychosis.
    Zhang T; Zeng J; Wei Y; Ye J; Tang X; Xu L; Hu Y; Liu H; Chen T; Li C; Wang J
    Neuropsychobiology; 2023; 82(2):104-116. PubMed ID: 36796338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.
    Zeni-Graiff M; Rizzo LB; Mansur RB; Maurya PK; Sethi S; Cunha GR; Asevedo E; Pan P; Zugman A; Yamagata AS; Higuchi C; Bressan RA; Gadelha A; Brietzke E
    Schizophr Res; 2016 Oct; 176(2-3):191-195. PubMed ID: 27424266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EEG microstates as biomarker for psychosis in ultra-high-risk patients.
    de Bock R; Mackintosh AJ; Maier F; Borgwardt S; Riecher-Rössler A; Andreou C
    Transl Psychiatry; 2020 Aug; 10(1):300. PubMed ID: 32839449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines, cortisol and IGF-1 in first episode psychosis and ultra high risk males. Evidence for TNF-α, IFN-γ, ΤNF-β, IL-4 deviation.
    Karanikas E; Manganaris S; Ntouros E; Floros G; Antoniadis D; Garyfallos G
    Asian J Psychiatr; 2017 Apr; 26():99-103. PubMed ID: 28483103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of structural brain correlates of neurological soft signs in individuals at ultra-high risk for psychosis.
    Wang Y; Braam EE; Wannan CMJ; Van Rheenen TE; Chan RCK; Nelson B; McGorry PD; Yung AR; Lin A; Brewer WJ; Koutsogiannis J; Wood SJ; Velakoulis D; Pantelis C; Cropley VL
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1475-1485. PubMed ID: 34467451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder.
    Hughes HK; Yang H; Lesh TA; Carter CS; Ashwood P
    J Neuroinflammation; 2022 Dec; 19(1):287. PubMed ID: 36463221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
    Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
    Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ
    Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for increased immune mobilization in First Episode Psychosis compared with the prodromal stage in males.
    Karanikas E; Griveas I; Ntouros E; Floros G; Garyfallos G
    Psychiatry Res; 2016 Oct; 244():333-8. PubMed ID: 27517343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant cerebro-cerebellar functional connectivity and minimal self-disturbance in individuals at ultra-high risk for psychosis and with first-episode schizophrenia.
    Bang M; Park HJ; Pae C; Park K; Lee E; Lee SK; An SK
    Schizophr Res; 2018 Dec; 202():138-140. PubMed ID: 29925474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occipital Alpha Connectivity During Resting-State Electroencephalography in Patients With Ultra-High Risk for Psychosis and Schizophrenia.
    Liu T; Zhang J; Dong X; Li Z; Shi X; Tong Y; Yang R; Wu J; Wang C; Yan T
    Front Psychiatry; 2019; 10():553. PubMed ID: 31474882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight.
    Song X; Fan X; Song X; Zhang J; Zhang W; Li X; Gao J; Harrington A; Ziedonis D; Lv L
    Schizophr Res; 2013 Oct; 150(1):269-73. PubMed ID: 23968860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin serum levels correlate with inflammatory status in drug-naïve first-episode schizophrenia.
    Song X; Fan X; Zhang J; Zheng H; Li X; Pang L; Chen X; Zhang W; Harrington A; Ziedonis D; Lv L
    World J Biol Psychiatry; 2014 Sep; 15(7):546-52. PubMed ID: 24959913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.